Walleye Trading LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $7.94 Million - $16.7 Million	245,000 New	245,000 $16.7 Million
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $73,590 - $123,387	-3,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $118,128 - $163,714	-4,600 Reduced 58.23%	3,300 $114,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $89,640 - $144,936	3,600 Added 83.72%	7,900 $231,000
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $1.14 Million - $1.67 Million	-44,600 Reduced 91.21%	4,300 $110,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $915,372 - $1.22 Million	28,200 Added 136.23%	48,900 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $406,620 - $688,716	10,800 Added 109.09%	20,700 $897,000
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $404,459 - $679,106	-8,300 Reduced 45.6%	9,900 $625,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $684,208 - $1.43 Million	-16,400 Reduced 47.4%	18,200 $930,000
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $612,380 - $1.1 Million	-13,400 Reduced 27.92%	34,600 $2.75 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $530,595 - $677,547	-11,700 Reduced 19.6%	48,000 $2.33 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.23 Million - $1.47 Million	23,300 Added 64.01%	59,700 $3.14 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $1.1 Million - $1.48 Million	27,600 Added 313.64%	36,400 $1.93 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $277,552 - $410,696	8,800 New	8,800 $361,000
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $11,880 - $19,770	-300 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $8,910 - $13,710	300	300 $12,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account